CERVICAL CANCER INCIDENCE IN A POPULATION OF 41,202 WOMEN SCREENED BY CONVENTIONAL CYTOLOGY AT A SINGLE PRIVATE LABORATORY OF SOUTHEAST BRAZIL

Author(s)

Schultz MIO, Defavori R, Brito WR, Schultz L
Instituto de Anatomia Patologica, Santa Barbara d'Oeste, Brazil

OBJECTIVES : Current (2018-2019) estimated cervical cancer incidence in Brazil is 15.43/100.000 women yearly, but there is wide regional variation (25.62-9.97) with lowest incidence in the Southeast. Each new case caries high economic/social burden and population-based screening is ideal. Data from current strategies in the private scenario are scarce despite fundamental in the process of achieving the WHO goal (4/100.000).

METHODS : 41,202 women were assisted by a single private laboratory in the years 2017-2018 by conventional cytology screening, with adequate quality indicators. Of those, 218 were submitted to biopsy/surgery because of abnormal screening results (population 1). In parallel, tissue from another 208 women without previous known cytology were seen in the same laboratory (population 2). Precancerous lesions (CIN) grade 1 and 2/3 were considered low (LSIL) and high grade (HSIL).

RESULTS : Population 1 (in house screening): In the previous 3 years, 38.9% of women were screened once, 57% 2-3 times and 4% ≥4 times, with alteration (≥ASC-US) in 5.4%, 3,7% and 13.4% of exams in each subgroup, respectively. In the 218 biopsies, low grade lesions predominated (LSIL/HSIL=1.16), mostly in young women (85% <24-39y), while high grade lesions tended to occur a decade later (81.7% 25-49y). Invasive cancer was present in 6 (2.8%) patients (4/6 in 30-49y and 2/6 in >70y). Population 2 (unknown screening): high grade lesions predominated (LSIL/HSIL=0.67) and 22 (10.5%) patients had invasive cancer (2 relapses). All diagnoses showed a wider age distribution, including low grade lesions (which lost concentration in younger age) and the 20 cases of new invasive cancer (ranging from 25->70y).

CONCLUSIONS : Adequate screening enrollment was associated with earlier disease detection, leading to a cancer incidence (7.3/100.000) below the regional rate. Access to HR-HPV test is crucial to reach the ideal scenario, targeting the high risk population and providing additional opportunity for wider screening enrollment through self sampling.

Conference/Value in Health Info

2019-11, ISPOR Europe 2019, Copenhagen, Denmark

Code

PCN257

Topic

Clinical Outcomes, Epidemiology & Public Health, Health Policy & Regulatory, Health Service Delivery & Process of Care

Topic Subcategory

Health Disparities & Equity, Quality of Care Measurement, Relating Intermediate to Long-term Outcomes

Disease

Infectious Disease (non-vaccine), Oncology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×